Making it possible to cure smoking addiction
NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life.
NFL Biosciences is a biotechnology company pioneering innovative solutions through a breakthrough approach based on a standardized extract of tobacco leaf. NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
2006
Served areaWorldwide
Headquarters199 Rue HΓ©lΓ¨ne Boucher, 34170 Castelnau-le-Lez β France
5,234,612
IPOJuly 5, 2021
Stock exchange(s)Euronext Paris